Literature DB >> 8370738

Rationale for selective use of anaerobic blood cultures.

A J Morris1, M L Wilson, S Mirrett, L B Reller.   

Abstract

Because of the declining frequency of anaerobic bacteremia, routinely using half the collected blood volume for anaerobic culture has been challenged. There is no data indicating whether more clinically relevant isolates would be recovered if all or most of the given blood sample were cultured aerobically. In this two-part study, we reviewed cases of anaerobic bacteremia to determine what proportion occurred in situations when anaerobes would be expected and then estimated the yield of different culture approaches by reanalyzing the data from a large prospective clinical blood culture study. The records of 61 patients who had an anaerobic isolate (excluding Propionibacterium species) recovered only from an anaerobic bottle were examined to define clinical settings in which such isolates occur. Fifty-six (92%) patients had clinically important isolates, and the source of infection was obvious at the time of culture in 47 of the 56 (84%). Of 56 patients, 36 (64%) had abdominal signs and symptoms, including 12 with recent abdominal surgery. Of nine patients without an obvious source of infection, six were on high-dose steroids. Relative yields were compared for (i) one aerobic bottle and one anaerobic bottle (5 ml to each) for all blood cultures, (ii) two aerobic bottles (5 ml to each), or (iii) two aerobic bottles plus an extra anaerobic bottle (only for clinically suspected anaerobic sepsis) (5 ml to each). The third approach had the highest yield (475 isolates), because the routine use of two aerobic bottles recovered more Candida spp., members of the family Enterobacteriaceae, and nonfermenters than did the first approach (448 isolates) (P < 0.02), and clinically directed culturing for anaerobes would recover anaerobes missed with the second approach (458 isolates). Our data suggest that the use of two aerobic bottles with selective culturing for anaerobes could increase the number of clinically relevant isolates by at least 6% compared with the current practice of inoculating an aerobic bottle and an anaerobic bottle with equal volumes of blood.

Entities:  

Mesh:

Year:  1993        PMID: 8370738      PMCID: PMC265706          DOI: 10.1128/jcm.31.8.2110-2113.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Emergence of Clostridium tertium as a pathogen in neutropenic patients.

Authors:  M Thaler; V Gill; P A Pizzo
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

2.  Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.

Authors:  A E De Almeida; M De Uzeda
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

3.  Fluconazole resistance in Candida glabrata.

Authors:  D W Warnock; J Burke; N J Cope; E M Johnson; N A von Fraunhofer; E W Williams
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

4.  Clostridium tertium septicemia in patients with neutropenia.

Authors:  G Speirs; R E Warren; A Rampling
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

Review 5.  Mycoses caused by Candida lusitaniae.

Authors:  T L Hadfield; M B Smith; R E Winn; M G Rinaldi; C Guerra
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

6.  Recent experience with antimicrobial susceptibility of anaerobic bacteria: increasing resistance to penicillin.

Authors:  R S Edson; J E Rosenblatt; D T Lee; E A McVey
Journal:  Mayo Clin Proc       Date:  1982-12       Impact factor: 7.616

7.  Six-year retrospective survey of the resistance of Bacteroides fragilis group species to clindamycin and cefoxitin.

Authors:  H M Wexler; B Harris; W T Carter; S M Finegold
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

8.  Clostridium septicum infection and malignancy.

Authors:  M R Katlic; W M Derkac; W S Coleman
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

9.  Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.

Authors:  J Downes; J H Andrew
Journal:  Pathology       Date:  1988-07       Impact factor: 5.306

10.  Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

Authors:  G J Cuchural; F P Tally; N V Jacobus; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe; C Pierson
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

View more
  27 in total

1.  Controlled clinical comparison of BACTEC plus anaerobic/F to standard anaerobic/F as the anaerobic companion bottle to plus aerobic/F medium for culturing blood from adults.

Authors:  M L Wilson; S Mirrett; F T Meredith; M P Weinstein; V Scotto; L B Reller
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Update on detection of bacteremia and fungemia.

Authors:  L G Reimer; M L Wilson; M P Weinstein
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 3.  Blood cultures in newborns and children: optimising an everyday test.

Authors:  J P Buttery
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

Review 4.  Diagnosis of Bloodstream Infections in Children.

Authors:  Jennifer Dien Bard; Erin McElvania TeKippe
Journal:  J Clin Microbiol       Date:  2016-01-27       Impact factor: 5.948

5.  Value of anaerobic blood cultures in pediatrics.

Authors:  A Gené; E Palacín; J J García-García; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

6.  Relevance of routine use of the anaerobic blood culture bottle.

Authors:  Patrick Grohs; Jean-Luc Mainardi; Isabelle Podglajen; Xavier Hanras; C Eckert; A Buu-Hoï; E Varon; Laurent Gutmann
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

7.  Assessing how many blood cultures are needed for detecting bloodstream infections.

Authors:  Federico G Nicola
Journal:  J Clin Microbiol       Date:  2008-03       Impact factor: 5.948

8.  Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.

Authors:  R Robert; A Deraignac; G Le Moal; S Ragot; G Grollier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-21       Impact factor: 3.267

9.  Controlled clinical laboratory comparison of two supplemented aerobic and anaerobic media used in automated blood culture systems to detect bloodstream infections.

Authors:  R Ziegler; I Johnscher; P Martus; D Lenhardt; H M Just
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

10.  Continuous quality improvement for introduction of automated blood culture instrument.

Authors:  M Alfa; S Sanche; S Roman; Y Fiola; P Lenton; G Harding
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.